More News! 1 Aug 2019 Atlantic Healthcare’s Inflammatory Bowel Disease RNA Drug Fails Phase III Hopes of seeing an approved treatment for the inflammatory bowel condition pouchitis have been dashed as the UK company Atlantic Healthcare’s RNA drug has proved ineffective in a phase III trial. The trial tested Atlantic Healthcare’s RNA drug alicaforsen as a treatment for patients with pouchitis. Patients with this condition have their colon surgically replaced […] August 1, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Expert Advice 1 Aug 2019 How to Use Case Studies to Take Your Life Science Marketing Strategy to the Next Level To build a great relationship with a business partner, laying a foundation of trust is essential. But how can a potential partner trust you if they have no concept of how you work? Case studies can help communicate trust and show your potential partner how they can improve their life science marketing strategy by working […] August 1, 2019 - 6 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jul 2019 British Biotech Raises €11M to Market Personalized Medicine Test The UK biotech PredictImmune has raised €11M (£10M) in a Series B fundraising round to commercialize technology to predict the progress of inflammatory bowel disease in newly diagnosed patients. The funds will finance the global launch of PredictSURE IBD, a blood test that can identify patients with the most severe cases of inflammatory bowel disease, […] July 31, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jul 2019 Wellington Partners Raises €210M to Invest in European Life Sciences VC firm Wellington Partners has raised its fifth fund dedicated to investing in life science companies, with a major focus on those located in German-speaking countries. Wellington Partners has well surpassed its initial target of €150M for its fifth life sciences fund. With a total €210M raised, this new fund is more than double the […] July 31, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jul 2019 French Biotech’s Insulin Resistance Treatment Boosted by €67M Series A The French company Alizé Pharma III has raised a Series A round of €67M to push two peptide drugs into phase I, including a drug treating rare genetic conditions causing insulin resistance. The money will advance Alizé Pharma III’s two preclinical drugs into clinical trials, with phase I trials expected to begin in 2020. One […] July 31, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 30 Jul 2019 The First Approved NASH Therapy? Genfit is poised to become the first company to get a treatment for NASH to market — something that could happen as early as 2020, should its late 2019 phase III trial results be positive. I spoke to Dean Hum, the current COO and CSO of Genfit, to find out more about the company’s 20-year […] July 30, 2019 - 6 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jul 2019 Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an environmentally friendly crop pesticide inspired by llama antibodies. AgroSavfe will use the funds to develop and manufacture its lead protein fungicide on a commercial scale. The company aims to get approval from the US Environmental Protection Agency and launch the […] July 30, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Expert Advice 30 Jul 2019 How to Build a Winning Life Science Content Marketing Strategy The data are in. Content works. As the internet matured, buyers in all industries began educating themselves before making a buying decision. When prospects get in touch with you, they’ve likely made up their mind already. How, then, can you affect their decision? “Publish or perish” has been standard advice for scientists since the early […] July 30, 2019 - 12 minutesmins - By James Mathison Share WhatsApp Twitter Linkedin Email
News and Trends 29 Jul 2019 €43M Series C to Launch UK Company’s Home Hemodialysis Kit Quanta Dialysis Technologies has raised €43.2M ($48M) to fund the commercial launch of a device that makes home hemodialysis more straightforward and economical for kidney failure patients. The UK-based Quanta will use the money to launch its technology in the UK later this year, and also apply for FDA approval. The technology previously obtained a […] July 29, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 26 Jul 2019 This Biotech Makes Food for Space Missions Using Bacteria Time to head to Helsinki, Finland, this week! We’re visiting Solar Foods, a biotech using bacteria to produce protein-rich flour out of carbon dioxide and water. Mission: To develop a protein-rich powder that can be made with little more than bacteria, electricity and water. This production method could be more efficient and sustainable than traditional […] July 26, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jul 2019 French Biotech Aims for Chikungunya Vaccine First with €21M Fundraise The French vaccine developer Valneva has received a €21M ($23.4M) grant to catch up with the competition in commercializing the first potential vaccine for the chikungunya virus. Coming from the nonprofit Coalition for Epidemic Preparedness Innovations (CEPI), the grant will boost the manufacturing and development of Valneva’s vaccine for the tropical disease chikungunya, which causes […] July 25, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 25 Jul 2019 German Biotech Breath Therapeutics Acquired in Deal Worth up to €500M The Italian company Zambon has acquired the German biotech Breath Therapeutics for up to €500M, getting hold of its treatment for a rare lung disease known as popcorn lung. The deal includes an upfront payment of €140M and up to €360M upon reaching undisclosed regulatory milestones. Zambon will take over the development of a treatment […] July 25, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email